Vaccination News Home Page

http://bmj.com/cgi/content/abstract/324/7350/1361

Abridged text of this article PDF [abridged] of this article Full text of this article PDF of this article Email this article to a friend Respond to this article Read responses to this article See related This week in BMJ item Related editorials in BMJ PubMed citation Related articles in PubMed Download to Citation Manager Search Medline for articles by: D'Souza, A. L || Bulpitt, C. J Alert me when: New articles cite this article

BMJ 2002;324:1361 ( 8 June )
 

Papers

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

Aloysius L D'Souza, research fellow,  Chakravarthi Rajkumar, senior lecturer and honorary consultant,  Jonathan Cooke, statistician,  Christopher J Bulpitt, professor of geriatric medicine. 

Correspondence to: A L D'Souza aloysius.dsouza@ic.ac.uk

Objective: To evaluate efficacy of probiotics in prevention and treatment of diarrhoea associated with the use of antibiotics.
Design: Meta-analysis; outcome data (proportion of patients not getting diarrhoea) were analysed, pooled, and compared to determine odds ratios in treated and control groups.
Identification: Studies identified by searching Medline between 1966 and 2000 and the Cochrane Library.
Studies reviewed Nine randomised, double blind, placebo controlled trials of probiotics.
Results: Two of the nine studies investigated the effects of probiotics in children. Four trials used a yeast (Saccharomyces boulardii), four used lactobacilli, and one used a strain of enterococcus that produced lactic acid. Three trials used a combination of probiotic strains of bacteria. In all nine trials, the probiotics were given in combination with antibiotics and the control groups received placebo and antibiotics. The odds ratio in favour of active treatment over placebo in preventing diarrhoea associated with antibiotics was 0.39 (95% confidence interval 0.25 to 0.62; P<0.001) for the yeast and 0.34 (0.19 to 0.61; P<0.01 for lactobacilli. The combined odds ratio was 0.37 (0.26 to 0.53; P<0.001) in favour of active treatment over placebo.
Conclusions: The meta-analysis suggests that probiotics can be used to prevent antibiotic associated diarrhoea and that S boulardii and lactobacilli have the potential to be used in this situation. The efficacy of probiotics in treating antibiotic associated diarrhoea remains to be proved. A further large trial in which probiotics are used as preventive agents should look at the costs of and need for routine use of these agents.

 

© BMJ 2002

This article has been cited by other articles:

• Barbut, F., Meynard, J. L. (2002). Managing antibiotic associated diarrhoea. BMJ 324: 1345-1346 [Full text]  

Rapid Responses:

Read all Rapid Responses

Brewer's yeast and antibiotic associated diarrhoea

Andy Li

bmj.com, 7 Jun 2002 [Full text]

Related editorials in BMJ:

Managing antibiotic associated diarrhoea .

Frédéric Barbut and Jean Luc Meynard
BMJ 2002 324: 1345-1346. [Full text]  

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.